The aim of the news bulletin is to increase the awareness of adverse drug reactions amongst healthcare professionals, and to promote adverse reaction reporting to medicinal products. This issue includes the topics Serious skin reactions associated with allopurinol, Voluntary recall of Hydroxycut® products in Singapore, Reporting vaccine-related adverse events, Update on drotrecogin alfa (Xigris®) and increased risk of bleeding, Traditional medicines adulterated with steroids, Oral sodium phosphates (OSP) and renal toxicity and Reports of warfarin-glucosamine interaction.

Click here for the newsletter.